BCG Therapy (Bacillus Calmette-Guérin)

BCG therapy involves using a weakened form of the bacteria Bacillus Calmette-Guérin (originally developed as a vaccine for tuberculosis) to treat bladder cancer. When injected directly into the bladder, it stimulates the immune system to target and destroy cancer cells. This immunotherapy is effective mainly for early-stage bladder cancers and helps prevent recurrence. The treatment is generally well-tolerated, with possible mild side effects like bladder irritation or flu-like symptoms. BCG therapy harnesses the body's immune response to fight cancer more effectively, offering an important option alongside other treatments for bladder cancer management.